Density functional study of the enzymatic reaction catalyzed by a cyclin-dependent kinase

被引：29

作者：

Cavalli, A ^{[1
]}

De Vivo, M ^{[1
]}

Recanatini, M ^{[1
]}

机构：

[1] Univ Bologna, Dept Pharmaceut Sci, I-40126 Bologna, Italy

来源：

CHEMICAL COMMUNICATIONS | 2003年 / 11期

关键词：

D O I：

10.1039/b212618d

中图分类号：

O6 [化学];

学科分类号：

0703 ;

摘要：

Density functional theory (DFT) calculations were carried out to study the molecular mechanism of the phosphoryl transfer reaction catalyzed by cyclin-dependent kinases (CDKs). The DFT study presented here shows that CDKs catalyze the phosphoryl transfer reaction from ATP to the serine substrate through a single step mechanism with a S(N)2-like transition state.

引用

页码：1308 / 1309

页数：2

共 50 条

[31] Cyclin-Dependent Kinase Inhibitors as Anticancer Drugs
Krystof, Vladimir
Uldrijan, Stjepan
CURRENT DRUG TARGETS, 2010, 11 (03) : 291 - 302
[32] Plant cyclin-dependent kinase inhibitor gene
Wang, H.
Fowke, L.C.
Crosby, W.L.
Nature, 1997, 386 (6624):
[33] Cyclin-dependent kinase homologues of Plasmodium falciparum
Doerig, C
Endicott, J
Chakrabarti, D
INTERNATIONAL JOURNAL FOR PARASITOLOGY, 2002, 32 (13) : 1575 - 1585
[34] Cyclin-dependent kinase control of motile ciliogenesis
Vladar, E. K.
Stratton, M. B.
Stearns, T.
Axelrod, J. D.
MOLECULAR BIOLOGY OF THE CELL, 2015, 26
[35] Extraneuronal roles of cyclin-dependent kinase 5
Rosales, Jesusa L.
Lee, Ki-Young
BIOESSAYS, 2006, 28 (10) : 1023 - 1034
[36] Cyclin-dependent kinase-5 in neurodegeneration
Shelton, SB
Johnson, GVW
JOURNAL OF NEUROCHEMISTRY, 2004, 88 (06) : 1313 - 1326
[37] Ras versus cyclin-dependent kinase inhibitors
Lloyd, AC
CURRENT OPINION IN GENETICS & DEVELOPMENT, 1998, 8 (01) : 43 - 48
[38] Cyclin-dependent kinase inhibitors in malignant hematopoiesis
Schirripa, Alessia
Sexl, Veronika
Kollmann, Karoline
FRONTIERS IN ONCOLOGY, 2022, 12
[39] Cyclin-dependent Kinase 5 and Neurodegenerative Diseases
Song, Mingxue
Qiang, Yalong
Zhao, Xiulan
Song, Fuyong
MOLECULAR NEUROBIOLOGY, 2024, 61 (10) : 7287 - 7302
[40] Selectivity and potency of cyclin-dependent kinase inhibitors
Jayalakshmi Sridhar
Nagaraju Akula
Nagarajan Pattabiraman
The AAPS Journal, 8

← 1 2 3 4 5 →